Pzena Investment Management LLC lessened its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 17.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,649,346 shares of the insurance provider’s stock after selling 753,790 shares during the period. Humana makes up about 4.1% of Pzena Investment Management LLC’s portfolio, making the stock its 3rd largest holding. Pzena Investment Management LLC’s holdings in Humana were worth $1,392,481,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Pinnacle Wealth Planning Services Inc. increased its holdings in Humana by 21.8% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 151 shares of the insurance provider’s stock worth $58,000 after purchasing an additional 27 shares in the last quarter. Wilkerson Advisory Group LLC raised its position in shares of Humana by 24.6% in the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock valued at $66,000 after purchasing an additional 33 shares during the period. Cidel Asset Management Inc. grew its stake in Humana by 1.1% during the second quarter. Cidel Asset Management Inc. now owns 3,883 shares of the insurance provider’s stock valued at $1,542,000 after acquiring an additional 41 shares in the last quarter. Greenleaf Trust lifted its position in Humana by 1.7% during the third quarter. Greenleaf Trust now owns 2,524 shares of the insurance provider’s stock valued at $963,000 after purchasing an additional 41 shares during the last quarter. Finally, Bogart Wealth LLC grew its position in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
HUM has been the subject of a number of research analyst reports. Truist Financial raised their price target on Humana from $415.00 to $475.00 and gave the stock a “hold” rating in a research note on Monday, October 12th. Monness Crespi & Hardt raised Humana to a “buy” rating in a research report on Friday, October 9th. Wall Street Zen cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Sunday. Oppenheimer raised their target price on shares of Humana from $475.00 to $525.00 and gave the stock an “outperform” rating in a report on Monday, October 12th. Finally, Wolfe Research reiterated an “outperform” rating and set a $450.00 target price on shares of Humana in a report on Monday, August 24th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Humana currently has an average rating of “Moderate Buy” and an average price target of $453.30.
Check Out Our Latest Analysis on Humana
Humana Stock Performance
NYSE HUM opened at $417.32 on Thursday. The stock has a 50-day moving average of $402.73 and a 200 day moving average of $310.76. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $456.50. The stock has a market capitalization of $50.11 billion, a price-to-earnings ratio of 39.48, a PEG ratio of 2.57 and a beta of 0.65. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.
Humana Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 24th will be given a dividend of $0.8850 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Thursday, December 24th. Humana’s payout ratio is presently 33.49%.
Humana Profile
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Read More
- Five stocks we like better than Humana
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
